Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06525064 · ClinicalTrials.gov registry record · NA
Health-E You Efficacy Trial for Male Adolescents
A NA study, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 2,752
- Enrollment target
NCT06525064: Recruiting NA study, sponsored by Johns Hopkins University.
NCT06525064 is a NA study that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 2,752 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06525064, a NA study, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,752 participants
- Enrollment target
Study Summary
This study will involve evaluating Health-E You/Salud ìTu™, a web-based, pre-visit mobile app designed to support adolescent male youth and his clinicians in discussing sexual and reproductive health (SRH) topics and care. It will test its efficacy among male patients in clinical settings using a stepped wedge cluster randomized controlled trial design.
Primary Outcome
Higher score indicates greater self-efficacy for correct use of male condoms. This measure is scaled with range from 1 (very difficult) to 5 (very easy); range 7-35.
Interventions
- OTHER Health-E You app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,752 participants |
| Start Date | 2026-06-02 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06525064 shows while recruiting
NCT06525064 is an interventional study that assigns participants to a tested intervention. Its 2,752 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% higher).
The record links to 0 conditions, and to 1 intervention - of which Health-E You app is the first listed.
NCT06525064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06525064 about?
NCT06525064 is a clinical study titled "Health-E You Efficacy Trial for Male Adolescents". This study will involve evaluating Health-E You/Salud ìTu™, a web-based, pre-visit mobile app designed to support adolescent male youth and his clinicians in discussing sexual and reproductive health (SRH) topics and care. It will test its efficacy among male patients in clinical settings using a st...
What is the current status of trial NCT06525064?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,752 participants. The study started on 2026-06-02. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06525064?
The interventions under investigation include: Health-E You app (OTHER).
Who is sponsoring clinical trial NCT06525064?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06525064's enrollment target sits among peer trials
2,752 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06085833 · 2,706 participants · NA
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI